PAX5 and breast carcinoma: Besides, 236 cases of breast cancer patients (including 124 cases with PAX5 low expression and 112 cases with PAX5 high expression) were collected and analyzed, which results were consistent with the prediction that PAX5 over-expression was associated with worse prognosis (Fig. 6D).